Weixin Lu

589 total citations
13 papers, 499 citations indexed

About

Weixin Lu is a scholar working on Molecular Biology, Genetics and Clinical Biochemistry. According to data from OpenAlex, Weixin Lu has authored 13 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 3 papers in Clinical Biochemistry. Recurrent topics in Weixin Lu's work include Virus-based gene therapy research (3 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Weixin Lu is often cited by papers focused on Virus-based gene therapy research (3 papers), Cancer Research and Treatments (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Weixin Lu collaborates with scholars based in United States, China and Australia. Weixin Lu's co-authors include Zhongyun Dong, Corazon D. Bucana, Anne-Marie Byrne, Conor C. Lynch, D. Bouchier-Hayes, Susan McDonnell, Judith H. Harmey, Fahao Zhang, Isaiah J. Fidler and Bo Feng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and International Journal of Cancer.

In The Last Decade

Weixin Lu

13 papers receiving 486 citations

Peers

Weixin Lu
Anahit Aghvanyan United States
Ian Daniels United Kingdom
R. Kim Japan
Kook Heon Seo South Korea
Magdalena B. Flak United Kingdom
Weixin Lu
Citations per year, relative to Weixin Lu Weixin Lu (= 1×) peers Vitaly I. Pozdeev

Countries citing papers authored by Weixin Lu

Since Specialization
Citations

This map shows the geographic impact of Weixin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixin Lu more than expected).

Fields of papers citing papers by Weixin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixin Lu. The network helps show where Weixin Lu may publish in the future.

Co-authorship network of co-authors of Weixin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weixin Lu. A scholar is included among the top collaborators of Weixin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixin Lu. Weixin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Lu, Weixin, et al.. (2020). Bilateral Dysplastic Gangliocytoma with Concurrent Polyostotic Fibrous Dysplasia: A Case Report and Literature Review. World Neurosurgery. 141. 421–424. 1 indexed citations
2.
Lu, Weixin, et al.. (2015). Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis. Renal Failure. 37(5). 751–756. 14 indexed citations
3.
Liu, Fengjing, et al.. (2012). Frequency of TLR 2, 4, and 9 Gene Polymorphisms in Chinese Population and Their Susceptibility to Type 2 Diabetes and Coronary Artery Disease. SHILAP Revista de lepidopterología. 2012. 1–7. 50 indexed citations
4.
Lu, Weixin, et al.. (2011). Association of AGER gene G82S polymorphism with the severity of coronary artery disease in Chinese Han population. Clinical Endocrinology. 75(4). 470–474. 5 indexed citations
5.
Lu, Weixin & Bo Feng. (2010). The -374A Allele of the RAGE Gene As a Potential Protective Factor for Vascular Complications in Type 2 Diabetes: A Meta-Analysis. The Tohoku Journal of Experimental Medicine. 220(4). 291–297. 21 indexed citations
6.
Zhang, Weihua, Rachel Tsan, Do‐Hyun Nam, Weixin Lu, & Isaiah J. Fidler. (2006). Loss of Adhesion in the Circulation Converts Amelanotic Metastatic Melanoma Cells to Melanotic by Inhibition of AKT. Neoplasia. 8(7). 543–550. 19 indexed citations
7.
Lu, Weixin & Alan J. Schroit. (2005). Vascularization of Melanoma by Mobilization and Remodeling of Preexisting Latent Vessels to Patency. Cancer Research. 65(3). 913–918. 14 indexed citations
8.
Ozawa, Shutaro, Weixin Lu, Corazon D. Bucana, et al.. (2003). Regression of primary murine colon cancer and occult liver metastasis by intralesional injection of lyophilized preparation of insect cells producing murine interferon-β. International Journal of Oncology. 22(5). 977–84. 7 indexed citations
9.
Harmey, Judith H., Corazon D. Bucana, Weixin Lu, et al.. (2002). Lipopolysaccharide‐induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion. International Journal of Cancer. 101(5). 415–422. 213 indexed citations
10.
Zhang, Fahao, Weixin Lu, & Zhongyun Dong. (2002). Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice.. PubMed. 8(9). 2942–51. 44 indexed citations
11.
Cao, Guangwen, et al.. (2001). Adenovirus-mediated interferon-β gene therapy suppresses growth and metastasis of human prostate cancer in nude mice. Cancer Gene Therapy. 8(7). 497–505. 55 indexed citations
12.
Lu, Weixin, Isaiah J. Fidler, & Zhongyun Dong. (1999). Eradication of primary murine fibrosarcomas and induction of systemic immunity by adenovirus-mediated interferon beta gene therapy.. PubMed. 59(20). 5202–8. 33 indexed citations
13.
Dong, Zhongyun, Shin‐Hun Juang, Rakesh Kumar, et al.. (1998). Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene. Cancer Immunology Immunotherapy. 46(3). 137–146. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026